Skip to main content
Equibles

UBS Group AG

Position in BTAIQ — BioXcel Therapeutics, Inc.

CIK 1610520 ZURICH, V8
Back to BTAIQ Full portfolio

Position in BTAIQ

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$222,870
+$152,136 QoQ
Shares Held
158,065
+199.4% QoQ
Ownership
0.505%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 47 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BTAIQ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. BTAIQ ranks #51 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,643,241 $261,803,294
2 ELAN
Elanco Animal Health Inc
 9,910,822 $243,905,327
3 UTHR
UNITED THERAPEUTICS Corp
 220,616 $119,536,366
4 VTRS
Viatris Inc
 6,092,296 $96,745,659
5 LNTH
Lantheus Holdings, Inc.
 835,494 $92,689,703
6 HIMS
Hims & Hers Health, Inc.
 2,660,810 $92,250,281
7 NBIX
Neurocrine Biosciences Inc
 545,937 $92,012,220
8 TEVA
Teva Pharmaceutical Industries Ltd
 2,140,065 $72,505,400

All Filings in BTAIQ

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $222,870 158,065
2026-03-31 $70,734 52,788
2025-12-31 $61,344 38,340
2025-09-30 $111,466 43,542
2025-06-30 $72,185 39,882
2025-03-31 $206,608 101,778
2024-12-31 — 1,276,893
2024-09-30 — 13,228
2024-06-30 — 52,483
2024-03-31 — 147,157
2023-12-31 — 48,320
2023-09-30 — 78,604
2023-06-30 — 110,936
2023-03-31 — 160,289
2022-12-31 — 139,214
2022-09-30 — 143,388
2022-06-30 — 117,020
2022-03-31 — 180,564
2021-12-31 — 199,933
2021-09-30 — 215,725
2021-06-30 — 160,603
2021-03-31 — 197,369
2020-12-31 — 91,949
2020-09-30 — 87,903
2020-06-30 — 80,874
2020-03-31 — 86,535